↓ Skip to main content

PLOS

Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic, Malawi

Overview of attention for article published in PLOS ONE, February 2013
Altmetric Badge

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
205 Mendeley
Title
Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic, Malawi
Published in
PLOS ONE, February 2013
DOI 10.1371/journal.pone.0056248
Pubmed ID
Authors

Hannock Tweya, Caryl Feldacker, Sam Phiri, Anne Ben-Smith, Lukas Fenner, Andreas Jahn, Mike Kalulu, Ralf Weigel, Chancy Kamba, Rabecca Banda, Matthias Egger, Olivia Keiser

Abstract

Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of important issues.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
Switzerland 2 <1%
Malawi 1 <1%
Kenya 1 <1%
Tanzania, United Republic of 1 <1%
South Africa 1 <1%
Brazil 1 <1%
Peru 1 <1%
India 1 <1%
Other 0 0%
Unknown 193 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 51 25%
Researcher 29 14%
Student > Ph. D. Student 21 10%
Other 16 8%
Student > Bachelor 16 8%
Other 37 18%
Unknown 35 17%
Readers by discipline Count As %
Medicine and Dentistry 83 40%
Nursing and Health Professions 20 10%
Social Sciences 14 7%
Agricultural and Biological Sciences 7 3%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Other 33 16%
Unknown 42 20%